Recent NTRC News
New Structural Insights into Arginase-1, a Target for Cancer Immunotherapy
X-ray protein crystal structure of human Arginase-1 with the small molecule inhibitor CB-1158. New structural [...]
A Precision Medicine Platform to Predict the Clinical Response to Chemo- and Immunotherapy
At the 2019 ELRIG Drug Discovery Conference 'Looking Back To The Future', NTRC will present on a predictive [...]
Expression of tumor cell markers and PD-L1 on primary patient-derived cells
Expression of tumor cell markers and PD-L1 on primary material of ovarian cancer patients by flow cytometry. Grey [...]
OUR PREMIUM BENEFITS
Integration of cancer biology and big data analysis
Identification of patient selection markers
Side-by-side comparison with known anti cancer agents
Finding targeted and novel synergistic combinations
Science driven technology platforms
Short turnaround times
Oncolines™